Trials / Sponsors / Thiogenesis Therapeutics, Inc.
Thiogenesis Therapeutics, Inc.
Industry · 3 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | A Dose-ranging Study of TTI-0102 in Adults and Children With Leigh Syndrome Spectrum (LSS) Leigh Syndrome | Phase 2 | 2025-10-01 |
| Recruiting | A Study to Assess TTI-0102 vs Placebo in MELAS Patients MELAS Syndrome, Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-like Episodes (MELAS) | Phase 2 | 2025-05-12 |
| Withdrawn | Study of Cysteamine-pantetheine Disulfide (TTI-0102) in Mild to Moderate COVID-19 COVID-19, COVID-19 Acute Respiratory Distress Syndrome | Phase 2 | 2024-09-27 |